Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Long-Term Deferred Tax (2024 - 2025)

Profound Medical (PROF) has 2 years of Long-Term Deferred Tax data on record, last reported at $66000.0 in Q4 2025.

  • For Q4 2025, Long-Term Deferred Tax fell 24.14% year-over-year to $66000.0; the TTM value through Dec 2025 reached $66000.0, down 24.14%, while the annual FY2025 figure was $66000.0, 24.14% down from the prior year.
  • Long-Term Deferred Tax reached $66000.0 in Q4 2025 per PROF's latest filing, down from $80000.0 in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $101000.0 in Q2 2025 and bottomed at $66000.0 in Q4 2025.